公司資料
Merus 股價、新聞與催化劑
- 股票代碼:
- MRUS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Netherlands
股價為何變動
Current closing-price context is not available for MRUS.
公司概覽
業務概覽
Merus is a clinical-stage antibody company focused on precision oncology and bispecific antibody development. Its platform is built around engineered immunology and cancer programs.
所在地與產業分類
Headquartered in the Netherlands and listed on NASDAQ as an ADR, Merus has a global biotechnology footprint.
商業模式特徵
The business depends on clinical data, platform validation, and the ability to create differentiated oncology assets.
生技產業定位
Merus is a platform antibody name with meaningful upside if its bispecific science keeps validating clinically.
未來催化劑
- Merus's catalysts are petosemtamab and zenocutuzumab, with the next data updates deciding whether the bispecific oncology story keeps strengthening. The company still needs the next readout to make the platform feel more than promising.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。